Survivors of diffuse large B-cell lymphoma (DLBCL) may experience impaired immune health, as discussed here by Tanaya Shree, MD, Stanford University Medical Center, California, CA, who explains the results of a large population-based study. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

свернуть